Skip to content

Anxiety research published in 2023

Page 2 of 17: studies 21 to 40 of 328, newest first. Back to the anxiety overview

Studies

Altered stakes: Identifying gaps in the informed consent process for psychedelic-assisted therapy trials

Journal of Psychedelic Studies November 20, 2023 Tahlia R. Harrison 23 citations

Abstract Background and aims Psychedelic-assisted therapy (P-AT) has been shown to reduce post-traumatic stress disorder (PTSD), depression, and anxiety symptoms, and is likely to be approved in the United States (US) in the coming years. However, concerns about participant safety in these early trials have surfaced, including allegations of sexual misconduct. This paper aims to illuminate how...

DOI: 10.1556/2054.2023.00267 (opens in new tab) Full text (opens in new tab) Anxiety Clinical trial Informed consent Inclusion mineral +5

Novel Psilocin Prodrugs with Altered Pharmacological Properties as Candidate Therapies for Treatment-Resistant Anxiety Disorders

Journal of Medicinal Chemistry November 20, 2023 Kaveh Matinkhoo, Lisa Yu, David Press et al. 18 citations

The psychedelic prodrug psilocybin has shown therapeutic benefits for the treatment of numerous psychiatric conditions. Despite positive clinical end points targeting depression and anxiety, concerns regarding the duration of the psychedelic experience produced by psilocybin, associated with enduring systemic exposure to the active metabolite psilocin, pose a barrier to its therapeutic...

Subjective Effects of a Single Dose of Ayahuasca among College Students with Harmful Alcohol Use: Qualitative Analysis of Participant Accounts

Psychoactives November 17, 2023 Anna Beatriz Vicentini, Lucas Silva Rodrigues, Giordano Novak Rossi et al. 4 citations

Alcohol is the recreational drug most frequently consumed, and its high frequency of use can lead to worsening social, psychological, and domestic issues. The age group most susceptible to alcohol dependence is 18- to 24-year-old youths, demanding interventional tools to target early involvement risks. Ayahuasca seems to be a promising therapeutic tool since evidence suggests it presents...

Mindfulness Based Cognitive Therapy on the Anxiety Reduction in 3rd Trimester of Pregnant Women

Journal of Maternal and Child Health November 16, 2023 Runjati Runjati, Mardiyono Mardiyono

Background: Untreated pregnancy anxiety can have a significant impact on the pregnancy and postpartum outcomes. Causing mental disorders during pregnancy has an increased risk and adverse effects on the mother and fetus. Mindfulness Based Cognitive Therapy (MBCT) can increase awareness about the function of thought patterns in daily activities and is able to control awareness of thoughts,...

Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis

Journal of Psychoactive Drugs November 15, 2023 Anees Bahji, Isis Lunsky, Gilmar Gutierrez et al. 21 citations

There has been a resurgence in psychedelic research for managing psychiatric conditions in recent years. This study aimed to present a comprehensive review of the current state of the field by applying a systematic search strategy for articles on the effectiveness and tolerability of four psychedelic-assisted therapies (psilocybin, lysergic acid diethylamide [LSD],...

DOI: 10.1080/02791072.2023.2278586 (opens in new tab) Full text (opens in new tab) PTSD Psychedelic-assisted therapies Anxiety disorders Mental health treatment +3

The Therapeutic Potential of Amphetamine-like Psychostimulants

Life November 8, 2023 Bruno Pires, Luana M. Rosendo, Ana Teresa Brinca et al. 15 citations

This review delves into the therapeutic applications of amphetamine-type stimulants such as lisdexamphetamine dimesylate, mixed amphetamine salts, 3,4-methylenedioxymethamphetamine (MDMA), dextroamphetamine, and phentermine. These compounds have been investigated for their potential in treating a range of psychiatric disorders, including attention deficit hyperactivity disorder (ADHD), drug...

DOI: 10.3390/life13112180 (opens in new tab) MDMA Anxiety Dextroamphetamine Phentermine +2

Effect Of Mindfulness Based Cognitive Therapy (MBCT) on Anxiety and Blood Pressure for Hypertension: A scoping review

Citra Delima Scientific journal of Citra Internasional Institute November 6, 2023 Ady Irawan Am, Anjani Janmabhumi, Ziara Arum Wulandari et al.

Hypertension, a prevalent and chronic medical condition, is often associated with elevated anxiety levels, contributing to its progression and complications. Mindfulness-Based Cognitive Therapy (MBCT) has emerged as a potential intervention to address both anxiety and hypertension. This scoping review aims to explore the existing literature on the effect of MBCT on anxiety and blood pressure in...

The Potential Therapeutic Benefits and Safety of Psychedelics in the Treatment of Mental Health Conditions: A Systematic Review

Journal of Sociology, Psychology & Religious Studies November 6, 2023 Sarah Naher, Sarah Naher 1 citation

Mental illnesses pose social, economic, and health burdens worldwide. The increasing health burden and mental diseases pose the need for investigating other potential medications. The present review focuses on psychedelic medications. The Patient/Participant, Intervention, Outcomes, and Studies ([PICOS) protocol and the Preferred Reporting Items for Systematic Reviews (PRISMA) checklist guided...

The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses.

Psychological Medicine November 2023 Matthew N Hill, Margaret Haney, Cecilia J. Hillard et al.

Cannabis is well established to impact affective states, emotion and perceptual processing, primarily through its interactions with the endocannabinoid system. While cannabis use is quite prevalent in many individuals afflicted with psychiatric illnesses, there is considerable controversy as to whether cannabis may worsen these conditions or provide some form of therapeutic benefit. The...

36 Impact of Neuropsychological Performance and Anxiety on Meditation in Drug Resistant Epilepsy (DRE) Patients Implanted with a Responsive Neurostimulation (RNS) Device

Journal of the International Neuropsychological Society November 1, 2023 Adam Saad, Lea Tortelero, Sloane Sheldon et al. 1 citation

Objective: Responsive neurostimulation (RNS) is a surgical intervention to reduce the frequency of seizures as an adjunctive therapy for patients with drug-resistant epilepsy (DRE). Presurgical neuropsychological evaluations capture symptoms of anxiety and depression, which occur in higher rates within the epilepsy population than in the general population; however, the effects of mood are...

Mindfulness training modifies attentional bias to facial emotion and emotional symptoms.

Journal of Psychiatric Research November 1, 2023 Hui Kou, Wei Luo, Xinnan Liu et al. 11 citations

Mindfulness training has been shown to improve emotional symptoms such as anxiety and depressive symptoms. However, its cognitive-behavioral mechanism is still unclear. The present study aimed to investigate the effect of mindfulness training on attention to emotional faces and its role in the improvement in emotional symptoms. Eighty participants were recruited and randomly divided into a...

Exploring the uses of yoga nidra: An integrative review.

Journal of Nursing Scholarship November 1, 2023 Susan Musto, April Hazard Vallerand 21 citations

The purpose of this paper was to review and synthesize published research articles that have utilized yoga nidra as an intervention. Yoga nidra is a form of guided meditation that has emerged in the literature in the past two decades as an intervention for a variety of medical conditions such as stress and mental health. It differs from traditional yoga, in that it does not require yoga poses....

The influence of hatha yoga on stress, anxiety, and suppression: A randomized controlled trial.

Acta Psychologica November 1, 2023 Bence Szaszkó, Rebecca Rosa Schmid, Ulrich Pomper et al. 20 citations

Engaging in yoga may mitigate stress and anxiety in individuals while potentially enhancing one's capacity to manage distractions. Our research aimed to explore the relation between these two outcomes: Can an eight-week yoga program foster distraction suppression, thereby reducing stress and discomfort? To answer this question, we used Hatha Yoga, the most commonly practiced form of yoga. We...

RETRACTED ARTICLE: Social media usage and students’ social anxiety, loneliness and well-being: does digital mindfulness-based intervention effectively work?

BMC Psychology October 31, 2023 Li Sun Retracted

Abstract Background The increasing integration of digital technologies into daily life has spurred a growing body of research in the field of digital psychology. This research has shed light on the potential benefits and drawbacks of digital technologies for mental health and well-being. However, the intricate relationship between technology and psychology remains largely unexplored. Purpose...

OVERCOMING ANXIETY CHRONIC KIDNEY FAILURE PATIENTS WITH SPIRITUAL MINDFULNESS INTERVENTION: A CASE STUDY

Nursing Sciences Journal October 31, 2023 Tata Mahyuvi, Novita Sari

ABSTRACT Chronic kidney failure sufferers experience many changes in their lives, including changes in diet management, exercise, control of blood sugar, urea, creatinine and kidney function replacement therapy, so they are prone to experiencing anxiety. The aim of this case study is to carry out nursing care to overcome anxiety problems in kidney failure patients with spiritual mindfulness...

The Quasi-experimental in Mixed Method: Mindfulness-Based Acceptance Therapy and Cognitive Behavioral Therapy in Test Anxiety

Journal of Qualitative Research in Education October 30, 2023 Engin Büyüköksüz, Raşit Avci

T The aim of our study is to compare the effectiveness of Cognitive Behavioral Therapy (CBT) and Mindfulness-Based Acceptance Intervention (MBA) in decreasing the anxiety of students, which negatively impacts academic achievement. A mixed-methods design was employed in the study. The experimental part is a quasi-experimental one including the pre-test, post-test, and control group. Data were...

Single dose of psilocybin improves depressive symptoms in Phase 2 study

The Brown University Psychopharmacology Update October 30, 2023

A single 25‐mg dose of psilocybin administered with psychological support led to significant and sustained improvement in depressive symptoms compared with placebo in a Phase 2 study of patients with major depressive disorder. A higher number of adverse events occurred in the psilocybin group, but no serious treatment‐emergent adverse events were reported. Study results were published online...

The Relationship among School Mindfulness, Classroom Anxiety, and High School Student Life Satisfaction

Educational Challenges October 27, 2023 Husna Riaz, Yumna Ali

Purpose. The study aims to improve student life throughout the school years by exploring the use of mindfulness-based instruction to reduce classroom anxiety. Many school systems in Asia do not use mindful based instruction at primary, secondary and high school education. Emphasis on academic achievement as measured in terms of grade scoring and competitive exam results is high, and leads to...

A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues

October 27, 2023 Sarah Kratina, Christopher Lo, Robert Schwartz et al. preprint

ABSTRACTBackground: Psychedelic substances are increasingly recognized for their therapeutic potential to ease psychological suffering linked to end-of-life issues. However, amid renewed scientific and public interest, policy remains restrictive. Existing reviews have made progress in synthesizing the results of studies of psychedelic interventions, especially psilocybin, and particularly with...

DOI: 10.31234/osf.io/4gfyd (opens in new tab) Anxiety Psychological intervention Systematic review Coping psychology +6

Extended difficulties following the use of psychedelic drugs: A mixed methods study

PLoS One October 24, 2023 Jules Evans, Oliver Robinson, Eirini K. Argyri et al. 166 citations

Long-term adverse experiences following psychedelic use can persist for weeks, months, or even years, and are relatively unexplored in psychedelic research. Our convergent mixed-method study gained quantitative and qualitative data from 608 participants who reported extended difficulties following psychedelic experiences. Data was gathered on the context of use, the nature and duration of the...